Evidence map›Paper›PMID 42251652›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Substrate-Controlled Enantiodivergence in Ni-Catalyzed Access to Phosphorylated Oxindoles With Quaternary Stereocenters.

Haimeng Zhu, Lewen Wang, Shihui Luo, Xinglong Zhang, Jun Joelle Wang

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haimeng ZhuDepartment of Chemistry, Hong Kong Baptist University, Hong Kong, China.
Lewen WangDepartment of Chemistry, Hong Kong Baptist University, Hong Kong, China.
Shihui LuoDepartment of Chemistry, Hong Kong Baptist University, Hong Kong, China.
Xinglong ZhangDepartment of Chemistry, The Chinese University of Hong Kong, Hong Kong, China.ORCID https://orcid.org/0000-0003-1698-692X
Jun Joelle WangDepartment of Chemistry, Hong Kong Baptist University, Hong Kong, China.ORCID https://orcid.org/0000-0001-9723-4054

Funding

Academic Equipment Fund 3036253Advanced Life Sciences and Mass Spectrometry LaboratoryCentral Research Computing Cluster, IT Service Centre at the Chinese University of Hong KongChinese University of Hong KongHKBU RC-SFCRG/23-24HKBU Faculty Niche Research Areas 2024/25Research Grants Council of Hong Kong GRF 12301223Research Grants Council of Hong Kong SRFS2526-2S02Research Startup Matching Support 5501779Vice Chancellor Early Career Professorship Scheme Research Startup Fund 4933634
6 · The paper itself

Abstract

A Ni-catalyzed enantioselective intermolecular Heck-phosphorylation of N-aryl acrylamides with phosphine oxides is developed. This redox-neutral cascade simultaneously forges C─C and C─P bonds, providing direct access to valuable 3,3-disubstituted phosphorylated oxindoles with quaternary stereocenters in good yields and high ee values. Notably, the reaction exhibits a unique substrate-controlled enantiodivergence: simply changing the leaving group (I vs. OTf) on the alkene partner switches the configuration of the product while employing the same enantiomer of the chiral catalyst. The synthetic utility is further demonstrated through product derivatizations. Density functional theory (DFT) calculations reveal that the leaving group dictates the order of migratory insertion versus anion exchange and, crucially, inverts the chiral environment at the enantioselectivity-determining oxidative addition transition state, providing a clear rationale for the observed stereodivergence.

Indexed as

asymmetric synthesiscascade reactionsheck reactionshomogeneous catalysisnickel

Identifiers

PMID42251652
PMCPMC13427142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.